Get practice-changing insight from UVA Cancer Center on methotrexate-based CNS prophylaxis for aggressive B-cell lymphoma.
Category: Cancer (Page 4)
A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
Discover the new worldwide leader in translational FUS immuno-oncology research.
A team of UVA Health researchers has found evidence that screening for STAT3 mutations will help to better classify and diagnose patients with LGL leukemia.
UVA Health lung cancer specialists will discuss the latest developments in lung cancer management. Bring your questions.
As providers, we have an opportunity to ensure patients are well informed about why screening is important, when it’s necessary and how it’s done.
Gwenalyn Garcia, MD, is a fellowship-trained hematologist and medical oncologist who cares for patients at UVA Cancer Center Augusta.
UVA Children's pediatric oncology researchers have developed a molecule to block a key determinant of T-ALL cell survival.
Blue light cystoscopy better pinpoints bladder cancer and improves access to life-saving surveillance after diagnosis.
Through a significant investment over 8 years, we became Virginia's first National Cancer Institute-designated comprehensive cancer center.